2023
DOI: 10.1039/d2sd00138a
|View full text |Cite
|
Sign up to set email alerts
|

Moving microcapillary antibiotic susceptibility testing (mcAST) towards the clinic: unravelling kinetics of detection of uropathogenic E. coli, mass-manufacturing and usability for detection of urinary tract infections in human urine

Abstract: Point-of-care antibiotic susceptibility test for urinary tract infections.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

1
4

Authors

Journals

citations
Cited by 5 publications
(3 citation statements)
references
References 61 publications
0
3
0
Order By: Relevance
“…38 Recently, moving microcapillary antibiotic susceptibility testing (mcAST) was introduced, which uses microcapillaries to identify E. coli , and a smartphone for observation of the results. 39 The markers employed in the early detection of urinary tract infection are mainly urine xanthine oxidase and myeloperoxidase. A microbiological study was conducted using VITEK, but this required skilled personnel and an appropriate laboratory set-up.…”
Section: Resultsmentioning
confidence: 99%
“…38 Recently, moving microcapillary antibiotic susceptibility testing (mcAST) was introduced, which uses microcapillaries to identify E. coli , and a smartphone for observation of the results. 39 The markers employed in the early detection of urinary tract infection are mainly urine xanthine oxidase and myeloperoxidase. A microbiological study was conducted using VITEK, but this required skilled personnel and an appropriate laboratory set-up.…”
Section: Resultsmentioning
confidence: 99%
“…In many systems, the detection of biomolecules occurs via the indirect detection of colour or fluorescence changes, with the most frequent examples including enzyme-linked immunosorbent assay (ELISA) and polymerase chain reaction (PCR) but also including many other biochemical reactions or interactions. These have included the detection of specific bacteria and pathogens [53], the presence of proteins or nucleic acid biomarkers [38,40,52], and the monitoring of mammalian [37] and bacterial cell growth [59]. These assays and biosensors can be miniaturised using microfluidics and then monitored using open-source hardware systems.…”
Section: Colour and Fluorescence Detection In Microfluidicsmentioning
confidence: 99%
“…Thus, there is a pressing need for the development of novel AST methodologies that can detect all resistance mechanisms and provide rapid, precise and consistent results to better inform antibiotic treatment strategies [8,12]. There have been several attempts at developing such methods in the last decade with a variety of approaches [13][14][15][16][17][18][19][20][21][22]. These rapid phenotypic methods suffer from inherent limitations that prevent them from becoming more widely adopted, including cost, reliance on databases, narrow antibiotic ranges and high false positive rates [23][24][25][26].…”
Section: Introductionmentioning
confidence: 99%